TVTXTravere Therapeutics, Inc.

$66.03

What is the market doing?

What the tape says about TVTX

Travere Therapeutics, Inc. is +252% over the past year while the S&P 500 is +20%: 231 points ahead of the market.

+252%

1-year return · S&P 500 +20%

vs 200-day average
+61%

vs 200-day average · a clear uptrend

RSI (14)
59

RSI (14) · neutral

Below its 52-week high
1.8%

Below its 52-week high

2024-08-15$7.77 – $67.22 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$66.03
1 monthS&P 500 −0.30%
+5.7%
1 yearS&P 500 +20%
+252%
5 yearsS&P 500 +85%
+364%
vs 50-day average$59.28
+11%
52-week high
$67.22
52-week low
$17.23
Annualised volatility
68%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.5M
Calendar-year price return
YearReturn
2026 (year to date)+73%
2025+119%
2024+94%
2023−57%
2022−32%
2021+14%
2020+92%
2019−37%
2018+7.4%
2017+11%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+0.72%
Feb106 of 10+2.3%
Mar103 of 10−6.7%
Apr105 of 10+2.9%
May104 of 10−5.2%
Jun106 of 10+7.9%
Jul116 of 11+1.9%
Aug116 of 11+6.7%
Sep115 of 11+6.2%
Oct105 of 10+3.8%
Nov105 of 10+2.1%
Dec106 of 10+5.6%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.